Beijing Key Laboratory of New Drug Development and Clinical Trial of Stem Cell Therapy is mainly responsible for the development of new drugs for stem cells in cell therapy scientific assessment of clinical conversion technology, quality control, technical reference sharing, storing clinical resources, technical training and so on. Our main purpose is to work out a complete set of stem cells, cell therapy clinical drug development transformation technology assessment and quality control system. We are the first in the country to build the basic research and clinical translation of combining and opening sharing of drug and technology of stem cells reference lab platform. With professional researchers’ hard work, we have constructed a set of specialized stem cells for a variety of incurable diseases, laboratory products and application platform for clinical translation needs, in order to meet the clinical department personnel to carry out research and development related to drug products, National Research Foundation of technology needs and clinical translational research technology needs.